Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;31(1):147-154.
doi: 10.1007/s00062-020-00876-4. Epub 2020 Jan 28.

The Contour-Early Human Experience of a Novel Aneurysm Occlusion Device

P Bhogal  1 , I Lylyk  2 , J Chudyk  2 , N Perez  2 , C Bleise  2 , P Lylyk  2
Affiliations

The Contour-Early Human Experience of a Novel Aneurysm Occlusion Device

P Bhogal et al. Clin Neuroradiol. 2021 Mar.

Abstract

Background and purpose: Endosaccular flow disruption is a recognized treatment options for treating both unruptured and ruptured aneurysms. The Contour device is designed to target the neck of an aneurysm and cause flow disruption within the aneurysm hence promoting thrombosis and neo-endothelialization at the neck. This article presents initial experiences with the Contour.

Methods: The prospectively maintained database was retrospectively reviewed to identify patients treated with the Contour device. Demographic data, aneurysm characteristics, clinical result, and clinical and radiological follow-up information were recorded.

Results: The review identified 3 patients (2 female), with 3 unruptured aneurysms, of average age 67 ± 8.7 years (range 62-77 years). The aneurysms were all located in the anterior circulation including one pericallosal, one at the A1-2 junction and one on the ICA bifurcation. The mean average dome height was 7.6 ± 0.62 mm (range 7.1-8.3 mm), dome width 5.7 ± 2 mm (range 3.5-7.5 mm), and neck width 3.6 ± 0.95 mm (range 2.5-4.2 mm). At follow-up angiography two of the aneurysms were completely occluded and one device had displaced into the aneurysm sac due to inappropriate positioning of the device. Of the patients one had minor stroke during the postoperative period but returned to baseline neurology. All patients were mRS 0 at last follow-up.

Conclusion: The Contour is a promising new aneurysm occlusion device. Further studies with longer term follow-up are required to determine the efficacy of this novel device.

Keywords: Aneurysm; Contour device; Intrasaccular flow diversion; Neck remodelling.

PubMed Disclaimer

References

    1. Pierot L, Gubucz I, Buhk JH, Holtmannspötter M, Herbreteau D, Stockx L et al. Safety and efficacy of aneurysm treatment with the WEB: results of the WEBCAST 2 study. AJNR Am J Neuroradiol. 2017;38:1151–5. - DOI
    1. Pierot L, Costalat V, Moret J, Szikora I, Klisch J, Herbreteau D et al. Safety and efficacy of aneurysm treatment with WEB: results of the WEBCAST study. J Neurosurg. 2016;124:1250–6. - DOI
    1. Pierot L, Spelle L, Molyneux A, Byrne J, WEBCAST and French Observatory Investigators. Clinical and anatomical follow-up in patients with aneurysms treated with the WEB device: 1‑year follow-up report in the cumulated population of 2 prospective, multicenter series (WEBCAST and French observatory). Neurosurgery. 2016;78:133–41. - DOI
    1. Fiorella D, Molyneux A, Coon A, Szikora I, Saatci I, Baltacioglu F et al. Demographic, procedural and 30-day safety results from the WEB intra-saccular therapy study (WEB-IT). J Neurointerv Surg. 2017;9:1191–6. - DOI
    1. van Rooij SBT, van Rooij WJ, Peluso JP, Sluzewski M, Bechan RS, Kortman HG et al. WEB treatment of ruptured Intracranial aneurysms: a single-center cohort of 100 patients. AJNR Am J Neuroradiol. 2017;38:2282–7. - DOI

LinkOut - more resources